RECRO NEWS
Just Released
upcoming events:
-
October 27th, 2010
Reborn: Opportunity Abounds in Biosciences
upcoming events:
October 27th, 2010
Biotech
November 9th &10th, 2010
Impact Conference, in Philadelphia
-
January 2010:
DEX-TD Phase I Clinical Study initiated.
December 2009:
William Ashton joins Board of Directors.
September 2009:
DEX-SL Phase I Clinical Study initiated in the U.S.
January 2010:
DEX-TD Phase I Clinical
Study initiated.
December 2009:
William Ashton joins Board
of Directors.
September 2009:
DEX-SL Phase I Clinical Study initiated in the U.S.
